Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning.

Zhao, Yu; Wu, Ping; Wu, Jianjun; Brendel, Matthias; Lu, Jiaying; Ge, Jingjie; Tang, Chunmeng; Hong, Jimin; Xu, Qian; Liu, Fengtao; Sun, Yimin; Ju, Zizhao; Lin, Huamei; Guan, Yihui; Bassetti, Claudio; Schwaiger, Markus; Huang, Sung-Cheng; Rominger, Axel; Wang, Jian; Zuo, Chuantao; ... (2022). Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning. European journal of nuclear medicine and molecular imaging, 49(8), pp. 2798-2811. Springer 10.1007/s00259-022-05804-x

[img]
Preview
Text
Zhao2022_Article_DecodingTheDopamineTransporter.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (6MB) | Preview

PURPOSE

This work attempts to decode the discriminative information in dopamine transporter (DAT) imaging using deep learning for the differential diagnosis of parkinsonism.

METHODS

This study involved 1017 subjects who underwent DAT PET imaging ([11C]CFT) including 43 healthy subjects and 974 parkinsonian patients with idiopathic Parkinson's disease (IPD), multiple system atrophy (MSA) or progressive supranuclear palsy (PSP). We developed a 3D deep convolutional neural network to learn distinguishable DAT features for the differential diagnosis of parkinsonism. A full-gradient saliency map approach was employed to investigate the functional basis related to the decision mechanism of the network. Furthermore, deep-learning-guided radiomics features and quantitative analysis were compared with their conventional counterparts to further interpret the performance of deep learning.

RESULTS

The proposed network achieved area under the curve of 0.953 (sensitivity 87.7%, specificity 93.2%), 0.948 (sensitivity 93.7%, specificity 97.5%), and 0.900 (sensitivity 81.5%, specificity 93.7%) in the cross-validation, together with sensitivity of 90.7%, 84.1%, 78.6% and specificity of 88.4%, 97.5% 93.3% in the blind test for the differential diagnosis of IPD, MSA and PSP, respectively. The saliency map demonstrated the most contributed areas determining the diagnosis located at parkinsonism-related regions, e.g., putamen, caudate and midbrain. The deep-learning-guided binding ratios showed significant differences among IPD, MSA and PSP groups (P < 0.001), while the conventional putamen and caudate binding ratios had no significant difference between IPD and MSA (P = 0.24 and P = 0.30). Furthermore, compared to conventional radiomics features, there existed average above 78.1% more deep-learning-guided radiomics features that had significant differences among IPD, MSA and PSP.

CONCLUSION

This study suggested the developed deep neural network can decode in-depth information from DAT and showed potential to assist the differential diagnosis of parkinsonism. The functional regions supporting the diagnosis decision were generally consistent with known parkinsonian pathology but provided more specific guidance for feature selection and quantitative analysis.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Zhao, Yu; Hong, Jimin; Bassetti, Claudio; Rominger, Axel Oliver and Shi, Kuangyu

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1619-7089

Publisher:

Springer

Language:

English

Submitter:

Pubmed Import

Date Deposited:

20 May 2022 14:41

Last Modified:

20 Jun 2022 00:15

Publisher DOI:

10.1007/s00259-022-05804-x

PubMed ID:

35588012

Uncontrolled Keywords:

Atypical parkinsonian syndrome Deep neural network Differential diagnosis Dopamine transporter imaging Parkinson’s disease

BORIS DOI:

10.48350/170133

URI:

https://boris.unibe.ch/id/eprint/170133

Actions (login required)

Edit item Edit item
Provide Feedback